Summary & Overview
CPT 95971: Electronic Analysis of Implanted Neurostimulator Pulse Generator
CPT code 95971 represents the electronic analysis of implanted neurostimulator pulse generator systems, a critical procedure in neurology for patients with conditions such as Parkinson's disease, epilepsy, essential tremor, multiple sclerosis, and migraine. This code is used when clinicians assess device parameters and patient measurements without reprogramming the neurostimulator, ensuring optimal device performance and patient safety.
Major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare provide coverage for this service. The procedure is most commonly performed in an office setting and is relevant for neurology, clinical neurophysiology, and pain medicine specialists.
Readers will gain insight into the clinical context of 95971, payer coverage details, and related billing codes. The publication also highlights associated modifiers and taxonomies, as well as common ICD-10 diagnoses linked to neurostimulator management. Key benchmarks and policy updates are provided to inform stakeholders about current trends and requirements for this essential neurology service.
CPT Code Overview
CPT code 95971 is used for the electronic analysis of implanted neurostimulator pulse generator systems. This procedure involves evaluating key parameters such as rate, pulse amplitude and duration, waveform configuration, battery status, electrode selectability, output modulation, cycling, impedance, and patient measurements. The analysis is performed without reprogramming the device.
This service falls under neurology and is typically conducted in an office setting (Place of Service 11). It is essential for ongoing management of patients with implanted neurostimulators, ensuring device functionality and patient safety.
Clinical & Coding Specifications
Clinical Context
A patient with an implanted neurostimulator pulse generator system, such as for the management of Parkinson's disease, essential tremor, epilepsy, multiple sclerosis, or migraine, presents to the neurology office for routine follow-up. The provider performs an electronic analysis of the device to assess parameters including rate, pulse amplitude and duration, waveform configuration, battery status, electrode selectability, output modulation, cycling, impedance, and patient measurements. No reprogramming of the device is performed during this visit. The analysis helps ensure the device is functioning properly and provides data for ongoing management of the patient's neurological condition.
Coding Specifications
-
Modifier
26: Indicates the professional component of the service, used when the physician interprets the results of the electronic analysis. -
Modifier
TC: Indicates the technical component, used when the facility provides the equipment and technical staff for the electronic analysis.
| Modifier Code | Description |
|---|---|
26 | Professional Component |
TC | Technical Component |
-
Associated Provider Taxonomies:
2084N0400X- Neurology Physician2081P2900X- Clinical Neurophysiology2084P0800X- Pain Medicine Physician
These taxonomies represent providers specializing in neurology, clinical neurophysiology, and pain medicine, all of whom may be involved in the management and analysis of neurostimulator devices.
Related Diagnoses
-
G25.0- Essential tremor- Patients with essential tremor may have implanted neurostimulators to help control tremor symptoms. Device analysis ensures optimal function.
-
G20- Parkinson's disease- Neurostimulators are commonly used in Parkinson's disease to manage motor symptoms. Routine analysis is part of ongoing care.
-
G40.909- Epilepsy, unspecified, not intractable, without status epilepticus- Implanted neurostimulators can be used in epilepsy management. Analysis checks device performance and battery status.
-
G35- Multiple sclerosis- Some patients with multiple sclerosis may benefit from neurostimulator devices for symptom management. Device analysis is performed to monitor function.
-
G43.909- Migraine, unspecified, not intractable, without status migrainosus- Neurostimulators may be used in refractory migraine cases. Analysis is necessary to ensure device efficacy and safety.
Related CPT Codes
-
95970- Electronic analysis of implanted neurostimulator pulse generator system, with reprogramming- Used when the device is analyzed and reprogrammed during the same session. This is an alternative to
95971when reprogramming is required.
- Used when the device is analyzed and reprogrammed during the same session. This is an alternative to
-
95972- Electronic analysis of implanted neurostimulator pulse generator system, with reprogramming, complex- Used for more complex reprogramming procedures, often involving multiple parameters or more advanced device adjustments. May be used instead of
95971when complexity warrants.
- Used for more complex reprogramming procedures, often involving multiple parameters or more advanced device adjustments. May be used instead of
-
63650- Percutaneous implantation of neurostimulator electrode array- Represents the surgical placement of the electrode array, typically performed prior to device analysis. Not commonly billed together with
95971unless part of a staged procedure.
- Represents the surgical placement of the electrode array, typically performed prior to device analysis. Not commonly billed together with
-
63685- Insertion or replacement of spinal neurostimulator pulse generator or receiver- Used for the surgical insertion or replacement of the pulse generator, which is the device analyzed in
95971. Usually performed before routine follow-up analysis.
- Used for the surgical insertion or replacement of the pulse generator, which is the device analyzed in
Codes 95970 and 95972 are alternatives to 95971 when reprogramming is performed. Codes 63650 and 63685 are related to the implantation and maintenance of the neurostimulator system.
National Reimbursement Benchmarks
National mean rates for CPT code 95971 show that UnitedHealth Group and Cigna have the highest average reimbursement, at $79.21 and $76.25 respectively. Blue Cross Blue Shield and BUCA (average commercial) rates are also notably higher than Medicare, with BUCA at $62.51 and Medicare at $51.85. The gap between Medicare and BUCA mean rates is $10.66, highlighting a significant difference between commercial and government payer averages.
Rate dispersion varies considerably across payers. Medicare exhibits the tightest range, with a difference of only $4.00 between the 75th and 25th percentiles, indicating minimal variation in rates. In contrast, UnitedHealth Group and Cigna show the widest dispersions, with ranges of $44.83 and $40.75 respectively, reflecting greater variability in commercial reimbursement. The table and chart below present the full breakdown of national benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.